RB..L Regulatory News (RB.)

22 April 2016

RECKITT BENCKISER GROUP PLC

Director Declaration

Reckitt Benckiser Group plc announces that Jaspal Bindra, a Non-Executive Director of Reckitt Benckiser Group plc, has been appointed as Executive Chairman of Centrum Group, with effect from 21 April 2016.

This notification is made in accordance with Listing Rule 9.6.14 of the FCA's Listing Rules.

Contact:

Christine Logan

Company Secretary

Reckitt Benckiser Group plc

01753 217800

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com

*RB is the trading name of the Reckitt Benckiser group of companies